Identification of the contagion risk among recovered as well as deceased COVID-19 patients
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$205,800Funder
Novo Nordisk FoundationPrincipal Investigator
N/A
Research Location
DenmarkLead Research Institution
Odense University HospitalResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The purpose of the project is to examine for how long the SARS-CoV-2 virus remains contagious after the infection symptoms have stopped. Currently, a safety margin of 48 hours after cessation of the symptoms is being applied, but we actually do not know if this is sufficient. Moreover, there is uncertainty about the extent to which and for how long COVID-19 is transmissible from deceased persons, which is particularly relevant for personnel handling the deceased. In this project, tests will be carried out where fresh samples from living as well as deceased COVID-19 patients are transferred to lab-grown human cells. By observing the cells and taking measurements, it can be established whether the samples contain a transmissible virus. The expectation is that the project will give a more precise picture of the contagion risk in connection with this virus, and thus contribute to formulating effective guidelines for reducing the spread of the disease.